Farther Finance Advisors LLC Purchases 603 Shares of Doximity, Inc. (NASDAQ:DOCS)

Farther Finance Advisors LLC grew its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 324.2% in the third quarter, HoldingsChannel.com reports. The firm owned 789 shares of the company’s stock after buying an additional 603 shares during the quarter. Farther Finance Advisors LLC’s holdings in Doximity were worth $34,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Janney Montgomery Scott LLC grew its stake in Doximity by 17.4% in the first quarter. Janney Montgomery Scott LLC now owns 20,802 shares of the company’s stock worth $560,000 after purchasing an additional 3,086 shares during the period. Oppenheimer Asset Management Inc. increased its stake in shares of Doximity by 18.9% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 15,320 shares of the company’s stock worth $412,000 after acquiring an additional 2,432 shares in the last quarter. Sei Investments Co. lifted its position in Doximity by 36.5% during the 1st quarter. Sei Investments Co. now owns 35,010 shares of the company’s stock valued at $942,000 after acquiring an additional 9,359 shares during the period. Russell Investments Group Ltd. boosted its stake in Doximity by 108.3% during the first quarter. Russell Investments Group Ltd. now owns 175,506 shares of the company’s stock worth $4,723,000 after acquiring an additional 91,240 shares in the last quarter. Finally, Blair William & Co. IL grew its holdings in Doximity by 31.7% in the first quarter. Blair William & Co. IL now owns 90,600 shares of the company’s stock worth $2,438,000 after purchasing an additional 21,787 shares during the period. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Price Performance

NASDAQ:DOCS opened at $52.05 on Friday. The company’s fifty day moving average price is $42.81 and its 200-day moving average price is $33.81. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $61.75. The firm has a market capitalization of $9.66 billion, a P/E ratio of 60.38, a PEG ratio of 5.08 and a beta of 1.30.

Wall Street Analyst Weigh In

DOCS has been the topic of a number of analyst reports. Canaccord Genuity Group cut shares of Doximity from a “buy” rating to a “hold” rating and upped their price target for the stock from $40.00 to $60.00 in a research note on Wednesday. Bank of America increased their price target on shares of Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a report on Monday, October 7th. Raymond James restated an “outperform” rating and issued a $65.00 price objective (up from $37.00) on shares of Doximity in a report on Friday, November 8th. Barclays increased their target price on Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research note on Monday. Finally, Canaccord Genuity Group reaffirmed a “hold” rating and set a $60.00 price target (up from $40.00) on shares of Doximity in a report on Wednesday. Ten analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $50.57.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.